EP0483152A4 - A method of reducing body weight and food intake using a dopamine d2 receptor agonist - Google Patents

A method of reducing body weight and food intake using a dopamine d2 receptor agonist

Info

Publication number
EP0483152A4
EP0483152A4 EP19900906612 EP90906612A EP0483152A4 EP 0483152 A4 EP0483152 A4 EP 0483152A4 EP 19900906612 EP19900906612 EP 19900906612 EP 90906612 A EP90906612 A EP 90906612A EP 0483152 A4 EP0483152 A4 EP 0483152A4
Authority
EP
European Patent Office
Prior art keywords
dopamine
body weight
receptor agonist
food intake
reducing body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900906612
Other languages
English (en)
Other versions
EP0483152A1 (fr
Inventor
James D. Belluzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitby Research Inc
Original Assignee
Whitby Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitby Research Inc filed Critical Whitby Research Inc
Publication of EP0483152A1 publication Critical patent/EP0483152A1/fr
Publication of EP0483152A4 publication Critical patent/EP0483152A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19900906612 1989-05-09 1990-04-19 A method of reducing body weight and food intake using a dopamine d2 receptor agonist Withdrawn EP0483152A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34909189A 1989-05-09 1989-05-09
US349091 1989-05-09

Publications (2)

Publication Number Publication Date
EP0483152A1 EP0483152A1 (fr) 1992-05-06
EP0483152A4 true EP0483152A4 (en) 1992-12-02

Family

ID=23370872

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900906612 Withdrawn EP0483152A4 (en) 1989-05-09 1990-04-19 A method of reducing body weight and food intake using a dopamine d2 receptor agonist

Country Status (3)

Country Link
EP (1) EP0483152A4 (fr)
AU (1) AU5439890A (fr)
WO (1) WO1990013294A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
KR20110043664A (ko) 2002-05-17 2011-04-27 듀크 유니버시티 비만치료방법
EP3281628B1 (fr) 2003-04-29 2019-09-11 Nalpropion Pharmaceuticals, Inc. Compositions pour influencer la perte de poids
EP1734955A2 (fr) 2004-01-13 2006-12-27 Duke University Compositions anticonvulsives, medicament antipsychotique et leurs methodes d'utilisation permettant d'influer sur la perte de poids
ES2402522T3 (es) 2005-11-22 2013-05-06 Orexigen Therapeutics, Inc. Composiciones y procedimientos para aumentar la sensibilidad a la insulina
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20160072276A (ko) 2006-11-09 2016-06-22 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
WO2009158114A1 (fr) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Procédés pour traiter des pathologies des graisses viscérales
ES2396066T3 (es) 2008-10-13 2013-02-19 Interquim, S.A. Procedimiento de obtención de los compuestos ópticamente activos (S)-(-)-2-(N-propilamino)-5-metoxitetralina y (S)-(-)-2-(N-propilamino)-5-hidroxitetralina
WO2011085331A1 (fr) 2010-01-11 2011-07-14 Orexigen Therapeutics, Inc. Méthodes permettant de faire perdre du poids à des patients souffrant d'une dépression sévère
KR20240090733A (ko) 2012-06-06 2024-06-21 오렉시젠 세러퓨틱스 인크. 과체중 및 비만의 치료 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189494A (en) * 1975-11-06 1980-02-19 Sandoz Ltd. Reducing free fatty acid of the blood and suppressing appetite
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 162, no. 1, 14th March 1989, pages 143-150, Elsevier Science Publishers B.V. (Biomedical Division); W. TIMMERMAN et al.: "Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437" *
PHYSIOLOGY & BEHAVIOR, vol. 44, nos. 4-5, 1988, pages 545-553, Pergamon Press plc, US; I.N. RUSK et al.: "Profile of the selective dopamine D-2 receptor agonist N-0437: its effects on palatability- and deprivation-induced feeding, and operant responding for food" *
See also references of WO9013294A1 *
SOC. NEUROSCI. ABSTR., vol. 12, 1986, page 1557, abstract no. 420.18; I. RUSK et al.: "Dopamine D1 and D2 receptors in relation to palatable food consumption in the rat" *
SOC. NEUROSCI. ABSTR., vol. 14, no. 1, 1988, page 614, abstract no. 249.6; I.N. RUSK et al.: "Microstructural analysis of feeding suppression and other behavioral changes induced by N-0437, a selective dopamine D2 agonist" *

Also Published As

Publication number Publication date
EP0483152A1 (fr) 1992-05-06
WO1990013294A1 (fr) 1990-11-15
AU5439890A (en) 1990-11-29

Similar Documents

Publication Publication Date Title
EP0483152A4 (en) A method of reducing body weight and food intake using a dopamine d2 receptor agonist
GB8901048D0 (en) A system of separately adjustable pillows
GB2224434B (en) A method of and apparatus for supporting the human body
ZA906764B (en) Sorbitol coated comestible and method of preparation
PL284935A1 (en) Method of aminating carbonitriles and iminonitriles
AU663830B2 (en) Apparatus and method for providing a multidimensional measurement of pain
ZA9410056B (en) Indoline derivatives method of preparation and use
ZA953140B (en) Naphthalene derivatives method of preparation and use
EP0428894A3 (en) Method of preparing a printing unit and printing unit adapted for this method
GB2246791B (en) Method of plating piston and apparatus thereof
GB8923571D0 (en) Connecting means and method of use thereof
EP0434899A3 (en) Compositions and articles for stimulating taste receptors
GB2234255B (en) Methylpolysilanes and method for their preparation
PL275765A1 (en) Preparation method for cumophenyl and/or its methyl derivatives
CS694688A1 (en) Method of 2-(methylaminoalcoxy) biphenyls and their hydrochlorides preparation
DK150089A (da) Solfanger med indbyggede akryllinser
CS40088A1 (en) Preparation with successive release of substance's niphedipine and method of its preparation
CS700388A1 (en) Method of methyliminoacetate's hydrochloride preparatio(
CS323288A1 (en) Acrylonitrile-butylacrylate latex and method of its preparation
BG48140A1 (en) Thiosulphanic derivatives of ethylaminopropionic amide and method for its preparing
PL271163A1 (en) Method of manufacturing and seating cylinder sleeves and device for chromium electroplating cylinder sleeves
CS51489A1 (en) Method of 1-methoxy-2-propanol preparation and device for its realization
CS763088A1 (en) Method of n-/(2-biphenylyloxy) alkyl/ piperazines and their hydrochlorides preparation
BG48143A1 (en) Benzylidenic derivatives of 3- phenylrodanine and method for its preparation
CS204188A1 (en) 3-(2-r-vinyl)-2-benzothiazolinones and method of their preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19911114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19921014

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19940913

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950124